Could a single cell treatment free liver transplant patients from daily anti-rejection pills?
NCT ID NCT05234190
First seen Mar 04, 2026 · Last updated May 24, 2026 · Updated 18 times
Summary
This study tests a new treatment called QEL-001, made from a patient's own cells, to prevent the body from rejecting a donated liver. The goal is to allow patients to safely stop taking anti-rejection drugs. The trial involves 33 adults who received a liver transplant 1 to 5 years ago and are currently on stable anti-rejection medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER DISEASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cambridge University Hospitals NHS Foundation Trust
Cambridge, CB2 0QQ, United Kingdom
-
G. Gergorio Maranon
Madrid, Spain
-
H. Clinic Barcelona
Barcelona, Spain
-
H. Saint Luc
Brussels, Belgium
-
Hopital Erasme
Brussels, Belgium
-
Hospital Reina Sofia
Córdoba, Spain
-
King's College Hospital NHS Foundation Trust
London, SE5 9RS, United Kingdom
-
Queen Elizabeth Hospital
Birmingham, United Kingdom
-
Royal Free London NHS Foundation Trust
London, NW3 2QG, United Kingdom
-
UZ Leuven
Leuven, 3000, Belgium
Conditions
Explore the condition pages connected to this study.